Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

CLN3 deficiency leads to neurological and metabolic perturbations during early development.

Title: CLN3 deficiency leads to neurological and metabolic perturbations during early development.
Authors: HEINS MARROQUIN, Ursula; SINGH, Randolph; PERATHONER, Simon; GAVOTTO, Floriane; Merino Ruiz, Carla; PATRASKAKI, Myrto; Gomez-Giro, Gemma; Kleine Borgmann, Felix; Meyer, Melanie; Carpentier, Anaïs; WARMOES, Marc Omer; Jäger, Christian; MITTELBRONN, Michel; SCHWAMBORN, Jens Christian; Cordero-Maldonado, Maria Lorena; CRAWFORD, Alexander; SCHYMANSKI, Emma; LINSTER, Carole
Source: Life Science Alliance, 7 (3) (2024-03)
Publisher Information: Life Science Alliance (LLC)
Publication Year: 2024
Collection: University of Luxembourg: ORBilu - Open Repository and Bibliography
Subject Terms: Life sciences; Sciences du vivant
Description: peer reviewed ; Juvenile neuronal ceroid lipofuscinosis (or Batten disease) is an autosomal recessive, rare neurodegenerative disorder that affects mainly children above the age of 5 yr and is most commonly caused by mutations in the highly conserved CLN3 gene. Here, we generated cln3 morphants and stable mutant lines in zebrafish. Although neither morphant nor mutant cln3 larvae showed any obvious developmental or morphological defects, behavioral phenotyping of the mutant larvae revealed hyposensitivity to abrupt light changes and hypersensitivity to pro-convulsive drugs. Importantly, in-depth metabolomics and lipidomics analyses revealed significant accumulation of several glycerophosphodiesters (GPDs) and cholesteryl esters, and a global decrease in bis(monoacylglycero)phosphate species, two of which (GPDs and bis(monoacylglycero)phosphates) were previously proposed as potential biomarkers for CLN3 disease based on independent studies in other organisms. We could also demonstrate GPD accumulation in human-induced pluripotent stem cell-derived cerebral organoids carrying a pathogenic variant for CLN3 Our models revealed that GPDs accumulate at very early stages of life in the absence of functional CLN3 and highlight glycerophosphoinositol and BMP as promising biomarker candidates for pre-symptomatic CLN3 disease.
Document Type: article in journal/newspaper
Language: English
ISSN: 2575-1077
Relation: urn:issn:2575-1077; https://orbilu.uni.lu/handle/10993/59553; info:hdl:10993/59553; https://orbilu.uni.lu/bitstream/10993/59553/1/e202302057.full.pdf; info:pmid:38195117
DOI: 10.26508/lsa.202302057
Availability: https://orbilu.uni.lu/handle/10993/59553; https://orbilu.uni.lu/bitstream/10993/59553/1/e202302057.full.pdf; https://doi.org/10.26508/lsa.202302057
Rights: open access ; http://purl.org/coar/access_right/c_abf2 ; info:eu-repo/semantics/openAccess
Accession Number: edsbas.61EC1BB
Database: BASE